Stay updated on Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The NAMSAL study record is now available, detailing a completed Phase 3 trial comparing dolutegravir- and efavirenz-based regimens for adults with HIV-1 in Cameroon, along with study criteria, outcomes, locations, and publications.
    Difference
    62%
    Check dated 2026-11-07T14:32:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-31T15:36:43.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The study record is now displayed, including its treatment arms, eligibility criteria, locations, outcomes, and publication history, rather than an access-denied error.
    Difference
    65%
    Check dated 2026-10-24T15:50:59.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:41:25.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T15:38:03.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study page now displays a 403 error page, replacing the previous content with an access-restricted view.
    Difference
    21%
    Check dated 2026-09-19T22:07:56.000Z thumbnail image

Stay in the know with updates to Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page.